Conflict of Interest Declaration
The ILCOR Continuous Evidence Evaluation process is guided by a rigorous ILCOR Conflict of Interest policy.
Task force members did not declare a conflict of interest.
Mike Wells (co-author on SR) developed the PAWPER method and holds the patent. He received no compensation that exceeds the cost of printing and distributing the tape. He had no role in the ILCOR PLS TF process. Independent risk of bias assessment and statistical analyses were performed.
CoSTR Citation
Tijssen JA, Wells M, Goldstein LN, Piscopo SP, Myburgh M, Acworth J, Scholefield BR, Morrison, LJ on behalf of the Pediatric Life Support Task Force. Methods of Calculating Drug Dose Calculation in Pediatric Resuscitation: Consensus on Science with Treatment Recommendations [Internet] Brussels, Belgium, International Liaison Committee on Resuscitation (ILCOR) Pediatric Life Support Task Force, 2026. Available from http://ilcor.org.
Methodological Preamble
This topic was chosen for review because it has never been systematically reviewed by ILCOR.
The continuous evidence evaluation process to produce this Consensus on Science with Treatment Recommendations started with an adolopment of a previously published SR. The adolopment process is designed to guide the adaptation of an existing published systematic review. The condition for proceeding with adolopment requires that the original SR is methodologically rigorous, assessed using the AMSTAR 2 checklist. The original SR by Wells, et al. (2017) “The accuracy of the Broselow tape as a weight estimation tool and a drug-dosing guide – A systematic review and meta-analysis”1 met all but one criterion as it was missing a published search strategy. The authors were contacted, and the search strategy was reviewed, modified and applied to all years to ensure the results of the original SR accurately reflected the existing evidence. At the Data Extraction stage, all included studies were compared to the studies included in the original SR, and all but two studies had been included in Wells et al. Thus, the Pediatric Task Force proceeded with the adolopment and extracted data for these two missing studies and all studies that were published after the 2017 SR’s end date of January 1, 2017 to December 19, 2025. There were no studies in this SR that reported True Positive, True Negative, False Positive, or False Negative results, thus GRADEpro evaluation of the evidence could not be performed.
Systematic Review
Tijssen JA, et al. Weight Estimation and Dose Calculation in Resuscitation: a Systematic Review and Meta-Analysis2
PICOST
The PICOST (Population,
Intervention, Comparator, Outcome, Study Designs and Timeframe)
Population: In pediatric patients(<18 years) requiring medications for resuscitation
Intervention: Does the Broselow tape (or similar length-based tape)
Comparison: Compared to any other instruments for drug dose calculation
Outcomes: Improve accuracy of weight estimation, and any clinical outcome (e.g., survival, neurologically favourable survival, ROSC, time to drug administration, drug dose accuracy)
Study Design: Systematic Reviews, RCTs and nonrandomized studies (non-RCTs, interrupted time series, controlled before-and-after studies, cohort studies, case series with >5 patients are eligible for inclusion. Unpublished studies (e.g., conference abstracts, trial protocols) and mannequin studies were excluded. Studies in non-resuscitation settings (e.g., schools, outpatient clinics) were included but downgraded in the risk of bias “selection” category and for indirectness in the GRADE certainty of evidence assessment. Studies conducted in non-healthcare settings were excluded, unless they used a methodology which included the intention to develop weight estimation methods for use in resuscitation settings.
All relevant publications in any language are included as long as there is an English abstract.
Timeframe: All years
Prospero ID: 42024516299
Changes to the original protocol to include non-length -based tapes as an Intervention (I) were submitted to PROSPERO as a major amendment.
The Risk of Bias was assessed for included studies both in the original SR and the additional studies identified in the updated search using the Newcastle-Ottawa Scale adapted for method-comparison studies. Studies were downgraded for major methodological flaws, such as incomplete data presentation, incomplete or erroneous data analysis, or inadequate reporting of outcome measures.2 Selective non-reporting or under-reporting was also assessed as part of the NOS. Each study received a score between 0 and 10 stars, with 7–10 indicating low risk of bias, 5-6 uncertain risk of bias, and 0–4 high risk of bias. To assess the certainty of the evidence, we evaluated each study using the GRADE framework for risk of bias (including design flaws), result inconsistency (heterogeneity), indirectness, imprecision, and statistical or methodological weaknesses.
Consensus on Science
The SR included 250 studies from 67 countries, 6 continents, and 9 million children studied over more than 5 decades2 There were 9 studies in children who required medications for resuscitation,3-11 including one in pediatric OHCA patients.4 Of these 9 studies, all investigated drug dose accuracy, and two also investigated time to drug administration. Due to the paucity of studies in children requiring resuscitation, we also included indirect populations and accounted for this in the certainty of evidence by downgrading for indirectness. For the critical outcomes of survival to hospital discharge and survival with favorable neurologic outcome as assessed by Pediatric Cerebral Performance Category there were no studies identified.
Time to Drug Administration
For time to drug administration, there were two studies enrolling 1,162 patients (uncertain ROB due to non-representative sample, partial investigation of confounders, lack of blinding, very low certainty of evidence downgraded for indirectness).12,13 One study demonstrated a 10 second advantage for a new rolling tape (p<0.001)12 and one study showed the same for the PAWPER tape with a dosing aid compared to the Broselow tape (p<0.0001).13
Drug Dose Accuracy
For drug dose accuracy, there were 15 studies,3,4,6-11,13-19 enrolling 5,287 children not in cardiac arrest and 145 children in OHCA (high ROB due to non-representative sample, inadequate sample size, retrospective design, partial investigation of confounders, lack of blinding; very low certainty of evidence). This study from 20064 with a low risk of bias and low certainty of evidence showed improvement in correct epinephrine dosing after mandating the use of the Broselow Tape and dosing guide (OR 3.0 (95% confidence interval [CI]: 1.4 – 6.6)). Compared to healthcare provider best-guess estimates, the Broselow Tape was superior14,20 (uncertain and high ROB, respectively) but the Broselow Tape was inferior to newer methods, including the Handtevy (uncertain ROB),6 PaedER tape (uncertain ROB),7 and the PAWPER tape (uncertain ROB)13 for drug dose accuracy. The SiTape (uncertain ROB)17 and AiRDose app (uncertain ROB)20 showed similar results to the Broselow Tape for drug dose accuracy. The proportion of patients with more than 10 or 20% dosing error using the Broselow Tape was reported in several studies: 28.3% (low ROB),7 40% (low ROB)9 and 60% (low ROB)3 for +/-20% error, and 44% (low ROB)10 for a 10% dosing error. Due to significant heterogeneity in sample size, effect size, and comparisons, a meta-analysis could not be performed for this outcome.
Accuracy of Weight Estimation
Accuracy of weight estimation was investigated in 139 studies that compared length-based tapes to other instruments for drug dose calculation (high ROB due to a variety of biases, detailed in “Supplementary Information 4” in SR2). Another 104 studies investigated non-length-based instruments for drug dose calculation (high ROB due to a variety of biases, detailed in “Supplementary Information 5” in SR2). References for these studies are available in the published SR. For weight estimation accuracy, overall certainty of evidence was considered low due to the observational design of all studies. Since most (236/243 studies for weight estimation accuracy) were indirect (i.e., not in resuscitation situations), certainty of evidence would be downgraded to very low; however, this is offset by an upgrade in certainty of evidence due to consistency of results in a high number of studies across large populations.
Estimation within 10% of actual weight (P10) for the Broselow Tape was evaluated in 103 studies and included 4,747,428 patients. Weight Estimation within 10% of Actual Weight (P10) shows the highest performing instrument to be the PAWPER tape, which was also first for LMIC. Parental estimate was 2nd most accurate. Age formulas were least accurate, consistently less than 50% of estimates were within 10% of actual weight.
Direct comparisons between the Broselow Tape and other instruments for accuracy of weight estimation (P10) were performed when there were at least 3 studies to pool data from. Instruments that were superior to the Broselow Tape for weight estimation accuracy were: Mercy Method (OR [95th % CI] 1.95 [1.37, 2.76]), parental estimate (OR [95th % CI] 2.37 [1.51, 3.73]), and PAWPER (OR [95th % CI] 2.48 [2.04, 3.02]). The Broselow Tape was superior to Handtevy (OR [95th % CI] 1.20 [1.07, 1.35]), Nelson formula (OR [95th % CI]1.63 [1.37, 1.93]), Australian Resuscitation Council (ARC) formula (OR [95th % CI]1.39 [1.19, 1.62]). There was no significant difference in the Broselow Tape compared to the finger-counting method (which uses fingers on both hands to match a child's age to an estimated weight in kilograms). Other direct comparisons were made; the PAWPER was superior to Mercy Method (OR [95th % CI] 1.81 [1.59, 2.07]), and parental estimate was superior to health care provider estimate (OR [95th % CI] 3.07 [2.61, 3.60]
Treatment Recommendation
To calculate the dose of resuscitation medications, use the child’s weight if known, including parental estimate (weak recommendation, low certainty of evidence).
To calculate the dose of resuscitation medications if the child’s weight is unknown, we suggest using a length-based method with habitus modification (including for underweight and overweight) and precalculated doses. This applies to children who fit within the limits of the length-based tapes (weak recommendation, low certainty of evidence).
Justification and Evidence to Decision Framework Highlights
Recent documentation of weight in a medical record or by parental estimate are likely to be the best sources for a known weight. In LMIC, parental estimate was consistently more accurate than length-based tapes for weight estimation.
If weight is unknown, use of length-based tapes with habitus modifications (e.g., the PAWPER tape) had superior weight estimation accuracy and drug dose accuracy. Age-based formulas were consistently inaccurate. The TF did not recommend against their use because there is a lack of evidence of harm. Age-based formulas allow for weight estimation remotely and in resource-limited settings where specialized equipment is unavailable. Dosing aids with weight-based precalculated doses improved drug dose accuracy.
These findings have consistently been reported across diverse populations around the world. However, the effect of the weight estimation inaccuracy on important patient outcomes has not been investigated, including in children with cardiac arrest. Studies of paediatric cardiac arrest through simulation show drug dose calculation results in a high cognitive load21 and is associated with worse quality of CPR metrics compared to adult resuscitation22, suggesting that an instrument’s ease of use is particularly important in cardiac arrest.
In summary, the task force considered weight estimation accuracy important for children requiring drugs for resuscitation but also valued other factors, such as ease of use, cost, and customizability of the instrument (for precalculated doses approved by local formulary). The PAWPER XL has higher weight-estimation accuracy than the Broselow Tape and age-based formulas, including in children who are underweight or have obesity, and can be used up to a length of 180 cm compared with 146.4 cm for the Broselow Tape. Age-based formulas have lower accuracy but require no equipment, have no length or age restriction, and may be used remotely. Although PAWPER XL involves two steps and requires some training, it is available in low-cost formats and can be customized to incorporate locally approved precalculated drug doses. The TF also recognized that the weight of importance of each of the factors may be different between various types of resuscitation.
Knowledge Gaps
There were no studies that investigated patient outcomes following resuscitation using a length-based tape or other methods for estimating weight and calculating drug doses. This needs to be studied prospectively and in diverse patients, teams, and locations and in patients with cardiac arrest.
There were no studies on resuscitation drug dosing based on length (approximates ideal body weight) compared to actual weight. Optimal dosing for select resuscitation drugs in underweight and overweight patients should be studied.
New weight estimation tools, such as smartphone applications, with pre-calculated drug dosing, should be trialed in children requiring resuscitation.
There were no studies on drug dosing in adolescents requiring resuscitation and thus it remains uncertain whether adolescents should be dosed according to adult recommendations or weight-based.
Evidence to Decision (EtD) Tables
4150 01 Evidence to Decision Table Et D November2026
References
1. Wells M, Goldstein LN, Bentley A, Basnett S, Monteith I. The accuracy of the Broselow tape as a weight estimation tool and a drug-dosing guide - A systematic review and meta-analysis. Resuscitation. 2017;121:9–33. doi: 10.1016/j.resuscitation.2017.09.026
2. Wells M, Goldstein LN, Bentley A. The accuracy of emergency weight estimation systems in children-a systematic review and meta-analysis. Int J Emerg Med. 2017;10:29. doi: 10.1186/s12245-017-0156-5
3. Hoyle JD, Davis AT, Putman KK, Trytko JA, Fales WD. Medication dosing errors in pediatric patients treated by emergency medical services. Prehosp Emerg Care. 2012;16:59–66. doi: 10.3109/10903127.2011.614043
4. Kaji AH, Gausche-Hill M, Conrad H, Young KD, Koenig WJ, Dorsey E, Lewis RJ. Emergency medical services system changes reduce pediatric epinephrine dosing errors in the prehospital setting. Pediatrics. 2006;118:1493–1500. doi: 10.1542/peds.2006-0854
5. Cooper B. Assessing Medication Error Rates in Pediatrics Pre and Post Implementation of the Handtevy App within the San Antonio Fire Department. In: University of Nebraska Medical Center. University of Nebraska; 2018:16.
6. Pukar KC, Jha A, Ghimire K, Shrestha R, Shrestha AP. Accuracy of Broselow tape in estimating the weight of the child for management of pediatric emergencies in Nepalese population. Int J Emerg Med. 2020;13:9. doi: 10.1186/s12245-020-0269-0
7. Kaufmann J, Uhl S, Singer E, Eifinger F, Klein T, Lechleuthner A, Engelhardt T, Wappler F, Bohmer A. Improving Pediatric Drug Safety in Prehospital Emergency Care-10 Years on. J Patient Saf. 2021;17:e1241–e1246. doi: 10.1097/PTS.0000000000000915
8. Shah MI, Ostermayer DG, Browne LR, Studnek JR, Carey JM, Stanford C, Fumo N, Lerner EB. Multicenter Evaluation of Prehospital Seizure Management in Children. Prehosp Emerg Care. 2021;25:475–486. doi: 10.1080/10903127.2020.1788194
9. Bosson N, Kaji AH, Gausche-Hill M. A Standardized Formulary to Reduce Pediatric Medication Dosing Errors: A Mixed Methods Study. Prehosp Emerg Care. 2022;26:492–502. doi: 10.1080/10903127.2021.1955058
10. Knudsen-Robbins C, Pham PK, Zaky K, Brukman S, Schultz C, Hecht C, Bacon K, Wickens M, Heyming T. Weighty Matters: A Real-World Comparison of the Handtevy and Broselow Methods of Prehospital Weight Estimation. Prehosp Disaster Med. 2022;37:616–624. doi: 10.1017/S1049023X22001248
11. Lim CA, Kaufman BJ, O'Connor J, Jr., Cunningham SJ. Accuracy of weight estimates in pediatric patients by prehospital Emergency Medical Services personnel. Am J Emerg Med. 2013;31:1108–1112. doi: 10.1016/j.ajem.2013.04.018
12. Jung JY, Kwak YH, Kim DK, Suh D, Chang I, Yoon C, Lee JC, Kim HC, Choi JY, Ahn H. An assessment of the accuracy of a novel weight estimation device for children. Emerg Med J. 2017;34:163–169. doi: 10.1136/emermed-2016-205817
13. Wells M, Goldstein L. Drug dosing errors in simulated paediatric emergencies - Comprehensive dosing guides outperform length-based tapes with precalculated drug doses. Afr J Emerg Med. 2020;10:74–80. doi: 10.1016/j.afjem.2020.01.005
14. Molyneux E, Brogan R, Mitchell G, Gove S. Children's weights: guess or measure by tape? Lancet. 1999;354:1616. doi: 10.1016/S0140-6736(99)04552-3
15. <Vilke-2001-Estimation of pediatric patient we1.pdf>.
16. Kriengsoontornkij W BP, Chakorn T. Correlation of emergency drug dose by using Broselow tape and Siriraj’s Thai Anthropometric Pediatric Estimate (SITAPE). Southeast Asian J Trop Med Public Health. 2017;48:29–35.
17. <Cooper-2018-Assessing Medication Error Rates i.pdf>.
18. Kaufmann J, Roth B, Engelhardt T, Lechleuthner A, Laschat M, Hadamitzky C, Wappler F, Hellmich M. Development and Prospective Federal State-Wide Evaluation of a Device for Height-Based Dose Recommendations in Prehospital Pediatric Emergencies: A Simple Tool to Prevent Most Severe Drug Errors. Prehosp Emerg Care. 2018;22:252–259. doi: 10.1080/10903127.2016.1248257
19. Waltuch T, Munjal K, Loo GT, Lim CA. AiRDose: Developing and Validating an Augmented Reality Smartphone Application for Weight Estimation and Dosing in Children. Pediatr Emerg Care. 2022;38:e1257–e1261. doi: 10.1097/PEC.0000000000002587
20. Vilke GM, Marino A, Fisher R, Chan TC. Estimation of pediatric patient weight by EMT-PS. J Emerg Med. 2001;21:125–128. doi: 10.1016/s0736-4679(01)00354-7
21. Ivankovic J, Bahr N, Meckler GD, Hansen M, Eriksson C, Guise JM. Identifying high cognitive load activities during simulated pediatric cardiac arrest using functional near-infrared spectroscopy. Resusc Plus. 2023;14:100409. doi: 10.1016/j.resplu.2023.100409
22. Hansen M, Walker-Stevenson G, Bahr N, Harrod T, Meckler G, Eriksson C, Guise JM. Comparison of Resuscitation Quality in Simulated Pediatric and Adult Out-of-Hospital Cardiac Arrest. JAMA Netw Open. 2023;6:e2313969. doi: 10.1001/jamanetworkopen.2023.13969